
Healthcare / Pharmaceuticals · NSE
Medistep Healthcare Limited, established in June 2023, is a pharmaceutical company involved in the production and trading of a variety of health and wellness products, including sanitary pads, energy powders, pharmaceutical and nutraceutical items, intimate care products, and surgical supplies. Focused on quality and growth, the company aims to expand its offerings as a public, non-government entity. As of December 30, 2024, it reported annualized revenue of ₹45 crore and a profit of ₹4.08 crore. The company had nine full-time employees, while additional labor needs are met through daily wage workers, with no contractual staff.
Price Band
₹43
Issue Size
₹16.10 Cr
Lot Size
3000 shares
GMP
+18.6%
Est. Listing
₹51
at current GMP
Subscribed
382.23x
overall
Open
8 Aug 2025
Close
12 Aug 2025
Allotment
13 Aug 2025
Refund
14 Aug 2025
Demat Credit
15 Aug 2025
Listing
18 Aug 2025
Last updated: 21 Nov 2025
Current Premium
Issue Price (Upper)
₹43
Band: ₹43
Estimated Listing Price
₹51
Upper price + GMP
Lot Size
3000 shares
Min investment ₹1,29,000
Estimated Profit / Lot
₹24,000
3000 × ₹8
Grey Market Premium trend
+₹8
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹8 | 18.6% | ₹51 |
| 30 Oct 2026 | +₹8 | 18.6% | ₹51 |
| 29 Oct 2026 | +₹7 | 16.7% | ₹50 |
GMP is unofficial market data. Not a guarantee of listing performance.
Medistep Healthcare Limited is bringing an initial public offering (IPO) in the Healthcare / Pharmaceuticals sector with an aggregate issue size of ₹16.1 Crores. The shares are offered at a price band of ₹43 to ₹43 per equity share on NSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 3000 shares (approx. ₹1,29,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Cameo Corporate Services Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-08-15, while un-allotted funds or UPI block mandates will be released on 2025-08-14.
The latest grey market premium for Medistep Healthcare Limited IPO is ₹8, which indicates an expected listing price of ₹51.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.